[Interferon-α induces disulfidptosis occurrence in human liver cancer cells]. [PDF]
Bi XY +5 more
europepmc +1 more source
[The value of the nutritional assessment index or score in prognostic evaluation for patients with liver cancer]. [PDF]
Shen JC +5 more
europepmc +1 more source
[Progress and application of liver organoids in the study of liver cancer]. [PDF]
Wang M +5 more
europepmc +1 more source
[ERI3 expression is elevated in hepatocellular carcinoma and correlates with poor patient prognosis]. [PDF]
Zhao X +8 more
europepmc +1 more source
[Strategies for immunotherapy-related hepatotoxicity in liver cancer]. [PDF]
Zhi Y, Mao YM.
europepmc +1 more source
[HDAC2-mediated H3K27 acetylation promotes the proliferation and migration of hepatocellular carcinoma cells]. [PDF]
Tang S +5 more
europepmc +1 more source
[Deubiquitinating enzyme MINDY1 is an independent risk factor for the maintenance of stemness and poor prognosis in liver cancer cells]. [PDF]
Xia BL +5 more
europepmc +1 more source
[Hepatocellular carcinoma-derived lactate-mediated histone H3K18 lactylation modifies S100A2 transcription to promote proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells]. [PDF]
Huang L, Shao Y, Zhou W, He J.
europepmc +1 more source
[Strategies for liver injury caused by hepatocellular carcinoma targeted therapy]. [PDF]
Zhao SX, Liu SH, Nan YM.
europepmc +1 more source
[SLC1A5 overexpression accelerates progression of hepatocellular carcinoma by promoting M2 polarization of macrophages]. [PDF]
Zou J, Wang H, Zhang D.
europepmc +1 more source

